Tower Research Capital LLC (Trc) Exicure, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.3 - $0.64 $45 - $96	151 Added 2.15%	7,183 $2,000
Q1 2024 May 15, 2024	BUY	$0.53 - $0.84 $31 - $49	59 Added 0.85%	7,032 $4,000
Q4 2023 Feb 13, 2024	SELL	$0.37 - $0.75 $7 - $14	-19 Reduced 0.27%	6,973 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.71 - $1.36 $149 - $285	210 Added 3.1%	6,992 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.85 - $1.44 $2,098 - $3,555	-2,469 Reduced 26.69%	6,782 $8,000
Q1 2023 May 09, 2023	BUY	$0.78 - $1.58 $1,149 - $2,328	1,474 Added 18.95%	9,251 $8,000
Q4 2022 Feb 10, 2023	BUY	$0.71 - $9.3 $3,914 - $51,280	5,514 Added 243.66%	7,777 $9,000
Q3 2022 Nov 10, 2022	BUY	$1.53 - $8.5 $498 - $2,771	326 Added 16.83%	2,263 $4,000
Q2 2022 Aug 15, 2022	BUY	$2.16 - $6.36 $4,183 - $12,319	1,937 New	1,937 $4,000

287K

Ticker XCUR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,962,580
Market Cap $92.7M
Description
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.